Serum soluble Toll-like receptor 4 and the risk of hepatocellular
carcinoma in hepatitis C virus patients

Código QR

Serum soluble Toll-like receptor 4 and the risk of hepatocellular carcinoma in hepatitis C virus patients

Guardado en:

Detalles Bibliográficos
Autores principales:	Maha Elkammah, Ahmed Gowily, Tarek Okda, Maha Houssen
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	afp hcv hcc stlr4. Medicine R
Acceso en línea:	https://doaj.org/article/482f22891e7d49d592ba3a08d6078e49
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Serum soluble toll-like receptor 2 and 4 as diagnostic and prognostic biomarkers for non-Hodgkin lymphoma
por: Nouran Fakhry, et al.
Publicado: (2020)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Saleh A. Alqahtani, et al.
Publicado: (2021)

DEMOGRAPHICS AND CORRELATION OF RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS PRESENTING TO A TERTIARY CARE FACILITY IN PAKISTAN
por: Hafsa Rashid, et al.
Publicado: (2021)

Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma
por: Mao S, et al.
Publicado: (2021)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021)

Industria de AFP chilena: ¿Cuánto gana y cuánto debería ganar?
por: López,Fernándo
Publicado: (2016)

GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinoma
por: Qian yun Ge, et al.
Publicado: (2021)

Expression and clinical significance of CMTM1 in hepatocellular carcinoma
por: Song Xin, et al.
Publicado: (2021)

Effect of MHC Linked 7-Gene Signature on Delayed Hepatocellular Carcinoma Recurrence
por: Fomaz Tariq, et al.
Publicado: (2021)

Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
por: Yunju Nam, et al.
Publicado: (2022)

HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
por: Xu Y, et al.
Publicado: (2021)

The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma
por: Yi Shi, et al.
Publicado: (2021)

Dipeptidyl Peptidase Inhibition Enhances CD8 T Cell Recruitment and Activates Intrahepatic Inflammasome in a Murine Model of Hepatocellular Carcinoma
por: James M. Henderson, et al.
Publicado: (2021)

Dual-Effect of Magnetic Resonance Imaging Reporter Gene in Diagnosis and Treatment of Hepatocellular Carcinoma
por: Zhou J, et al.
Publicado: (2020)

Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4
por: Xin Lu, et al.
Publicado: (2021)

The Genetic Profile and Serum Level of IL-8 Are Associated with Chronic Hepatitis B and C Virus Infection
por: Ednelza da Silva Graça Amoras, et al.
Publicado: (2021)

Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant
por: ACOSTA-RIVERO,NELSON, et al.
Publicado: (2009)

Altering retinol binding protein 4 levels in hepatitis C: Inflammation and steatosis matter
por: Ming-Ling Chang, et al.
Publicado: (2020)

Oral Lichen Planus and Hepatitis C virus Infection: an Epidemiological Study of 149 Cases
por: Hakkou,Fouzia, et al.
Publicado: (2012)

Gene Network Analysis of Hepatocellular Carcinoma Identifies Modules Associated with Disease Progression, Survival, and Chemo Drug Resistance
por: Ye H, et al.
Publicado: (2021)

A Comprehensive Coordinator Supported Hepatitis C Virus Testing and Linkage to Treatment Program at Kaiser Permanente Mid-Atlantic States
por: Mary Cabell Jonas, et al.
Publicado: (2021)

Changes of immune cells in patients with hepatocellular carcinoma treated by radiofrequency ablation and hepatectomy, a pilot study
por: Yu Zusheng, et al.
Publicado: (2021)

The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
por: Jie Zhu, et al.
Publicado: (2021)

Cyclin-Dependent Kinase 4 is expected to be a therapeutic target for hepatocellular carcinoma metastasis using integrated bioinformatic analysis
por: Jia-Ning Zhang, et al.
Publicado: (2021)

Automatic Time-Resolved Fluorescence Immunoassay of Serum Alpha Fetoprotein-L3 Variant via LCA Magnetic Cationic Polymeric Liposomes Improves the Diagnostic Accuracy of Liver Cancer
por: Wang K, et al.
Publicado: (2020)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Kylie E. Zane, et al.
Publicado: (2021)

Combination of three-dimensional reconstruction technique and blood parameters for the evaluation of tumor burden and prognosis in patients with hepatocellular carcinoma undergoing liver resection
por: Bibesh Pokhrel, et al.
Publicado: (2020)

Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes
por: Sun Y, et al.
Publicado: (2018)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Eun Jin Sun, et al.
Publicado: (2021)

Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma
por: Natthaphong Nimitrungtawee, et al.
Publicado: (2021)

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects
por: Ilaria Romito, et al.
Publicado: (2021)

Mitochondrial Genotoxicity of Hepatitis C Treatment among People Who Inject Drugs
por: Mélusine Durand, et al.
Publicado: (2021)

New markers of oxidative stress in lichen planus and the influence of hepatitis C virus infection – a pilot study
por: Mitran Madalina Irina, et al.
Publicado: (2021)

Dysregulated N6-methyladenosine (m6A) processing in hepatocellular carcinoma
por: Yue-fan Wang, et al.
Publicado: (2021)

Selenium sulfide disrupts the PLAGL2/C‐MET/STAT3‐induced resistance against mitochondrial apoptosis in hepatocellular carcinoma
por: Tianfeng Yang, et al.
Publicado: (2021)

Ribosomal Protein L23 Drives the Metastasis of Hepatocellular Carcinoma via Upregulating MMP9
por: Minli Yang, et al.
Publicado: (2021)

Methyltransferase-Like 3-Mediated m6A Methylation of Hsa_circ_0058493 Accelerates Hepatocellular Carcinoma Progression by Binding to YTH Domain-Containing Protein 1
por: Anqi Wu, et al.
Publicado: (2021)

Development of a Deep Learning Model to Assist With Diagnosis of Hepatocellular Carcinoma
por: Shi Feng, et al.
Publicado: (2021)

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Dafeng Xu, et al.
Publicado: (2021)

Dendritic cells in the pathogenesis of viral hepatitis C
por: Elena Removna Chernykh, et al.
Publicado: (2019)